REG - Zotefoams PLC - Nike Exclusivity Agreement Extension

ZotefoamsAnnouncement

06/06/2023 08:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230606:nRSF7823Ba&default-theme=true

RNS Number : 7823B  Zotefoams PLC  06 June 2023

Zotefoams plc

("Zotefoams")

 

Nike Exclusivity Agreement Extension

 

6 June 2023 - Zotefoams, a world leader in cellular materials technology, is
pleased to announce that its exclusivity agreement with Nike to develop
footwear technology and supply materials to the global footwear, apparel and
equipment company has been extended to 31 December 2029.

The agreement sets out the terms and conditions under which Zotefoams supply
Nike exclusively with high-performance foam materials within the footwear
industry.

 

Due to the confidentiality surrounding this agreement, Zotefoams is unable to
disclose the specific details of the agreement. Other than its length, all
other conditions within the agreement remain unchanged.

 

 

- Ends -

 

Enquiries:

 

 Zotefoams plc                         +44 (0) 208 664 1600
 David Stirling, Group CEO

 Gary McGrath, Group CFO
 IFC Advisory (Financial PR & IR)      +44 (0) 203 934 6630
 Graham Herring

 Tim Metcalfe

 Zach Cohen

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology
delivering optimal material solutions for the benefit of society. Utilising a
variety of unique manufacturing processes, including environmentally friendly
nitrogen expansion for lightweight AZOTE(®) polyolefin and
ZOTEK(®) high-performance foams, Zotefoams sells to diverse markets
worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT(®)
advanced insulation for demanding industrial markets. Zotefoams also owns and
licenses patented microcellular foam technology to reduce plastic use in
extrusion applications and for ReZorce(®) mono-material recyclable barrier
packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam
products manufacture and conversion), Massachusetts, USA and Stilling, Denmark
(microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com)

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks of
Zotefoams plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEAKKKELPDEEA